Li, W.; Zhu, S.; Liu, J.; Liu, Z.; Zhou, H.; Zhang, Q.; Yang, Y.; Chen, L.; Guo, X.; Zhang, T.;
et al. Zanubrutinib Ameliorates Cardiac Fibrosis and Inflammation Induced by Chronic Sympathetic Activation. Molecules 2023, 28, 6035.
https://doi.org/10.3390/molecules28166035
AMA Style
Li W, Zhu S, Liu J, Liu Z, Zhou H, Zhang Q, Yang Y, Chen L, Guo X, Zhang T,
et al. Zanubrutinib Ameliorates Cardiac Fibrosis and Inflammation Induced by Chronic Sympathetic Activation. Molecules. 2023; 28(16):6035.
https://doi.org/10.3390/molecules28166035
Chicago/Turabian Style
Li, Wenqi, Shuwen Zhu, Jing Liu, Zhigang Liu, Honggang Zhou, Qianyi Zhang, Yue Yang, Li Chen, Xiaowei Guo, Tiantian Zhang,
and et al. 2023. "Zanubrutinib Ameliorates Cardiac Fibrosis and Inflammation Induced by Chronic Sympathetic Activation" Molecules 28, no. 16: 6035.
https://doi.org/10.3390/molecules28166035
APA Style
Li, W., Zhu, S., Liu, J., Liu, Z., Zhou, H., Zhang, Q., Yang, Y., Chen, L., Guo, X., Zhang, T., Meng, L., Chai, D., Tang, G., Li, X., & Yang, C.
(2023). Zanubrutinib Ameliorates Cardiac Fibrosis and Inflammation Induced by Chronic Sympathetic Activation. Molecules, 28(16), 6035.
https://doi.org/10.3390/molecules28166035